432 filings
Page 10 of 22
6-K
bph96gujn2tfacw 5ic5
23 Apr 18
Intellipharmaceutics Receives Delisting Determination
12:00am
6-K
lt9mdot33t1c7orm
16 Apr 18
Annual & Special Meeting of Shareholders
12:00am
6-K
f4450
16 Apr 18
Primary Document
12:00am
D
ovb3mrnu
3 Apr 18
$1.01M in options / securities to be acquired, sold $1.01M, 5 investors
12:00am
6-K
u8605p
29 Mar 18
Primary Document
12:00am
6-K
b97nke8wy4ay97l1r10
22 Mar 18
Primary Document
12:00am
D
kuucxqf
21 Mar 18
$1.97M in options / securities to be acquired, sold $1.97M, 5 investors
12:00am
6-K
u37l64 7t
21 Mar 18
Intellipharmaceutics Announces Closing of US$ 1.8 Million Financing
12:00am
424B5
hzd0ex 01m37jpr
20 Mar 18
Prospectus supplement for primary offering
12:00am
6-K
zx7e6j9vxdipf0 fzz
20 Mar 18
Primary Document
12:00am
6-K
djn084u5kd3sobiy95h
19 Mar 18
Intellipharmaceutics Announces US$ 1.8 Million Registered Direct Offering
12:00am
6-K
bate6tu
19 Mar 18
Intellipharmaceutics Announces Closing of US$ 3.5 Million Financing
12:00am
6-K
ighjhb8lfouhh3 sm8h
16 Mar 18
Primary Document
12:00am
424B5
gh1whzfcjjwm3bnuwxk
16 Mar 18
Prospectus supplement for primary offering
12:00am
6-K
8ho3pexdfx950y6xgob
14 Mar 18
Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering
12:00am
424B3
bg2nwmy3ug4fw
14 Mar 18
Prospectus supplement
12:00am
6-K
85n0q
1 Mar 18
Primary Document
12:00am
6-K
4347piki38bi5pdn
16 Feb 18
Current report (foreign)
12:00am
6-K
2ogdk
14 Feb 18
Intellipharmaceutics Sets Earnings Release Date for Year End 2017 Results
12:00am